intermittent fasting with glp-1 and Here are my thoughts on

This is a common marketing tactic weve seen before - find people who are already desperate for change and provide them with a miracle fix that is also easy to obtain

La lgica es la siguiente: sin proteccin de patentes, ninguna empresa invertira miles de millones en investigacin si otra compaa pudiera copiar el medicamento inmediatamente sin haber asumido el riesgo econmico

The analysts said GLP-1 sales could reach $102 billion by 2030, of which obesity is projected to contribute $41 billion. Two leaders in this field are expected to take roughly 44% and 52% share, respectively, of the global GLP-1 market in 2030. With high financial gain predicted, supply issues have been raised concerning how companies will meet the growing demand

Operations for Novo Nordisk